Journal profile · SURGERYPERIPHERAL VASCULAR DISEASE&n-PERIPHERAL VASCULAR DISEASE
Journal of Vascular Surgery-Venous and Lymphatic Disorders
ISSN 2213-333X · eISSN 2213-3348 · Elsevier Inc. · ENGLAND
Journal of Vascular Surgery-Venous and Lymphatic Disorders: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.01; fully open access; APC about USD 2,400; median 91 days to acceptance (83 articles, last 24 months); 261 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Vascular Surgery-Venous and Lymphatic Disorders is published by Elsevier Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Venous Thromboembolism Diagnosis and Management, Diagnosis and Treatment of Venous Diseases and Central Venous Catheters and Hemodialysis, together about 59.3% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Vascular Surgery: Venous and Lymphatic Disorders aims to be the premier international journal of medical, endovascular and surgical care of venous and lymphatic disorders. It publishes high quality clinical research, techniques, and practice manuscripts related to all aspects of venous and lymphatic disorders, including malformations and wound care, with an emphasis on the practicing clinician. The journal seeks to provide novel and timely information to vascular surgeons, interventionalists, phlebologists, wound care specialists, and allied health professionals who treat patients presenting with vascular and lymphatic disorders. As the official publication of The Society for Vascular Surgery and the American Venous Forum, the Journal will publish, after peer review, selected papers presented at the annual meeting of these organizations, as well as original articles of affiliated vascular societies, and by members and non-members. www.jvsvenous.org
From the journal's Aims & Scope
Research area (LetPub): SURGERYPERIPHERAL VASCULAR DISEASE&n-PERIPHERAL VASCULAR DISEASE
Editor-in-chief Ruth L. BushPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 31, Italy 4, Australia 4, United Kingdom 2, Russia 2 (54 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Venous Thromboembolism Diagnosis and ManagementMedicine24.8%
- Diagnosis and Treatment of Venous DiseasesMedicine24.6%
- Central Venous Catheters and HemodialysisHealth Professions9.9%
- Vascular anomalies and interventionsMedicine5.4%
- Peripheral Artery Disease ManagementMedicine5.1%
- Dermatologic Treatments and ResearchMedicine4.2%
- Vascular Procedures and ComplicationsMedicine3.2%
- Lymphatic System and DiseasesMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
| Minor | Surgery | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Surgery | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
| Minor | Surgery | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.01LetPub ·
- Impact factor (publisher)
- 3.1Publisher website ·
- CiteScore 2026-06
- 5.9LetPub ·
- CiteScore (publisher)
- 5.9Publisher website ·
- SJR 2026-06
- 0.81LetPub ·
- SNIP 2026-06
- 1.6LetPub ·
- h-index
- 18LetPub ·
- h-index
- 72OpenAlex ·
- i10-index
- 851OpenAlex ·
- 2-year mean citedness
- 1.13OpenAlex ·
- Self-citation rate
- 12.9%LetPub ·
- Share of gold OA articles
- 69.21%LetPub ·
Volume
- Articles per year
- 126LetPub ·
Articles by year OpenAlex count · 3,428 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 247 | 247 | 29 |
| 2025 | 261 | 261 | 195 |
| 2024 | 242 | 242 | 620 |
| 2023 | 272 | 272 | 1,418 |
| 2022 | 260 | 260 | 1,783 |
| 2021 | 305 | 305 | 3,272 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
91 daysMedian, submission to acceptance · P25–P75 60 days – 144 days
- Acceptance to online
- median 8 days (79 articles)
- Submission to online
- median 111 days
- Sample
- 83 articles with submission and acceptance dates (377 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- First decision after review
- 39 daysPublisher website ·
- Submission to acceptance
- 78 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,400 / EUR 2,250 / GBP 1,920 / JPY 297,670 | — | — | |
| Publisher website | USD 2,400 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteArticle types accepted1, with length limits
- editorialion of the results and conclusions. The editorial should be objective and authoritative and should not exceed 1000 words in length. Even though Editorials are s…main text ≤ 1,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review
- AI use Declaration of Generative AI in Scientific Writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyze and draw insights from data as part of the research process. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human o…
Source ↗Publisher website ·- Authorship Authorship Criteria
Authorship Criteria Model summary
To qualify for authorship in a Journal of Vascular Surgery Publication, each author must have made a significant contribution to the conception or completion of the manuscript and is willing to share the responsibility for the content of the paper. Specifically, authorship is limited to those who made a direct and substantial contribution to each of the four following areas:Substantial contributio…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
The Journal of Vascular Surgery: Venous and Lymphatic Disorders is committed to publishing high quality articles free from commercial influence. DECLARATION OF COMPETING INTEREST. Corresponding authors, on behalf of all the authors of a submission, must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examp…
Source ↗Publisher website ·- Publication ethics
Similarity Check Model summary
Submitted manuscripts are subject to IThenticate Similarity Check screening.
Source ↗Publisher website ·- License & copyright Copyright
We offer authors a choice of user licenses, which define the permitted reuse of articles.
Source ↗Publisher website ·- Open access Open Access
Article Publishing Charge (APC): USD 2,400 (excluding taxes). Review this journal’s open access policy.
Source ↗Publisher website ·- Peer review Peer Review Process
Peer review type: single-anonymous Model summary
The Editors and reviewers, by providing prompt and authoritative review, aim to optimize the quality of the published papers. All submitted manuscripts are reviewed initially by the Editor-in-Chief and/or an Associate Editor. A submission may be rejected outright if it does not have sufficient merit to warrant further review or deals with subject matter outside the scope of the Journal. If your su…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2213-333X
- Electronic ISSN
- 2213-3348
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Vascular Surgery-Venous and Lymphatic Disorders
What CAS zone is Journal of Vascular Surgery-Venous and Lymphatic Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Vascular Surgery-Venous and Lymphatic Disorders is in Zone 2 of Medicine, and in Zone 2 of the minor category Peripheral Vascular Disease / Surgery. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Vascular Surgery-Venous and Lymphatic Disorders?
The latest impact factor listed by LetPub is 3.01; CiteScore 5.9, h-index 72.
How long does peer review take at Journal of Vascular Surgery-Venous and Lymphatic Disorders?
Based on the dates recorded on 83 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 60–144 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Vascular Surgery-Venous and Lymphatic Disorders based?
Of the 54 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (31), Italy (4) and Australia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Vascular Surgery-Venous and Lymphatic Disorders?
According to LetPub and DOAJ records, Journal of Vascular Surgery-Venous and Lymphatic Disorders is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE; that list has not been checked against each database.
Is Journal of Vascular Surgery-Venous and Lymphatic Disorders open access, and what is the APC?
Journal of Vascular Surgery-Venous and Lymphatic Disorders is a fully open-access journal. APC about USD 2,400.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .